Baidu
map

Neurology:见于活动性神经结节病的螺旋形髓静脉

2019-12-24 zyx 神经科病例撷英拾粹

47岁男性,活检证实为结节病,表现为认知功能下降和尿失禁6月。

47岁男性,活检证实为结节病,表现为认知功能下降和尿失禁6月。神经影像学检查符合活动性神经结节病,并可见明显的右侧髓静脉不对称扩张和螺旋形外观(图)。髓静脉扩张是近来描述的神经结节病的一种成像模式,可见于33%的患者。其出现机制尚不明确,可能由于静脉周围炎症或淋巴引流功能障碍所致。磁敏感加权成像通过定位脱氧血液的顺磁信号来突出静脉。髓静脉扩张是神经结节病的常见表现,可作为诊断标准之一,且可充当疾病活动的生物标志物。


(图:A:FLAIR可见右侧额叶和顶叶不对称脑回水肿[虚线];B:整个右侧半球均可见影脑膜[空心箭头]和软脑膜[实心箭头]强化;C-D:SWI可见右侧髓静脉扩张扭曲[白箭],相位衬度成像[phase-contrast imaging]上进一步证实)

原始出处:Caton MT Jr, Yau WW, Huang RY, Bhattacharyya S. Teaching NeuroImages: Corkscrew medullary veins in active neurosarcoidosis.Neurology. 2019 Nov 5;93(19):e1832-e1833.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2000939, encodeId=2dd42000939f7, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Fri Feb 21 10:11:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698013, encodeId=631a1698013ac, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Thu Nov 26 19:11:00 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723991, encodeId=f5131e23991cd, content=<a href='/topic/show?id=2d996516e7c' target=_blank style='color:#2F92EE;'>#活动性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65167, encryptionId=2d996516e7c, topicName=活动性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=596833562866, createdName=楚秀娟, createdTime=Tue Jul 21 21:11:00 CST 2020, time=2020-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991990, encodeId=6562199199067, content=<a href='/topic/show?id=7fbee44884b' target=_blank style='color:#2F92EE;'>#神经结节病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74488, encryptionId=7fbee44884b, topicName=神经结节病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Mon Mar 30 05:11:00 CST 2020, time=2020-03-30, status=1, ipAttribution=)]
    2020-02-21 hb2008ye
  2. [GetPortalCommentsPageByObjectIdResponse(id=2000939, encodeId=2dd42000939f7, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Fri Feb 21 10:11:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698013, encodeId=631a1698013ac, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Thu Nov 26 19:11:00 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723991, encodeId=f5131e23991cd, content=<a href='/topic/show?id=2d996516e7c' target=_blank style='color:#2F92EE;'>#活动性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65167, encryptionId=2d996516e7c, topicName=活动性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=596833562866, createdName=楚秀娟, createdTime=Tue Jul 21 21:11:00 CST 2020, time=2020-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991990, encodeId=6562199199067, content=<a href='/topic/show?id=7fbee44884b' target=_blank style='color:#2F92EE;'>#神经结节病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74488, encryptionId=7fbee44884b, topicName=神经结节病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Mon Mar 30 05:11:00 CST 2020, time=2020-03-30, status=1, ipAttribution=)]
    2020-11-26 fusion
  3. [GetPortalCommentsPageByObjectIdResponse(id=2000939, encodeId=2dd42000939f7, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Fri Feb 21 10:11:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698013, encodeId=631a1698013ac, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Thu Nov 26 19:11:00 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723991, encodeId=f5131e23991cd, content=<a href='/topic/show?id=2d996516e7c' target=_blank style='color:#2F92EE;'>#活动性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65167, encryptionId=2d996516e7c, topicName=活动性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=596833562866, createdName=楚秀娟, createdTime=Tue Jul 21 21:11:00 CST 2020, time=2020-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991990, encodeId=6562199199067, content=<a href='/topic/show?id=7fbee44884b' target=_blank style='color:#2F92EE;'>#神经结节病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74488, encryptionId=7fbee44884b, topicName=神经结节病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Mon Mar 30 05:11:00 CST 2020, time=2020-03-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2000939, encodeId=2dd42000939f7, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Fri Feb 21 10:11:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698013, encodeId=631a1698013ac, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Thu Nov 26 19:11:00 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723991, encodeId=f5131e23991cd, content=<a href='/topic/show?id=2d996516e7c' target=_blank style='color:#2F92EE;'>#活动性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65167, encryptionId=2d996516e7c, topicName=活动性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=596833562866, createdName=楚秀娟, createdTime=Tue Jul 21 21:11:00 CST 2020, time=2020-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991990, encodeId=6562199199067, content=<a href='/topic/show?id=7fbee44884b' target=_blank style='color:#2F92EE;'>#神经结节病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74488, encryptionId=7fbee44884b, topicName=神经结节病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Mon Mar 30 05:11:00 CST 2020, time=2020-03-30, status=1, ipAttribution=)]

相关资讯

LANCET:难治性活动性类风湿关节炎的新药物疗法!

sirukumab是一种以高亲和力选择性结合IL-6细胞因子的人单克隆抗体,正在开发用于治疗类风湿性关节炎和其他疾病。近期,一项发表在权威杂志LANCET上的文章评估了sirukumab在3期研究中用于类风湿性关节炎的功效和安全性。研究者们在来自20个国家(阿根廷,澳大利亚,奥地利,比利时,加拿大,法国,德国,意大利,日本,立陶宛,墨西哥,荷兰,波兰,葡萄牙,俄罗斯,韩国,西班牙,台湾,英国和美国

Ann Rheum Dis:依那西普与强直性脊柱炎活动性的关系

背景:曾有数据显示依那西普的水平与类风湿关节炎患者的临床反应有相关性。然而,对于强直性脊柱炎而言,针对类风湿关节炎的研究数据显然是不够合理的。目的:研究依那西普水平与AS病患临床反应之间的关系。方法:前瞻性观察队列研究,招募162例以依那西普治疗的强直性脊柱炎患者,观察其24周的治疗情况。依那西普的水平使用ELISA回顾性检测。疾病活动性使用强施行脊柱炎活动评分(ASDAS)评估,另外包括测定C-

Allergy:慢性自发性荨麻疹患者CRP与疾病活动性和治疗反应性有关!

由此可见,CRP水平升高在CSU患者中较为常见。CRP水平的评估可能有助于优化CSU患者的治疗。

Ann Rheum Dis:银屑病,尤忌吸烟(DANBIO注册研究)

目的:银屑病在常规护理中使用第一肿瘤坏死因子抑制剂(TNFi),本次旨在研究在这种治疗方式下吸烟对银屑病的活动性、依从性和治疗反应性的影响。方法:观察性队列研究,数据由丹麦全国性DANBIO登记处提供,通过吸烟状态分组(目前吸烟、曾吸烟、从不吸烟),采用K-M曲线、logistics和cox回归曲线分析治疗的依从性、反应性(ACR20/50/70、SULAR良好反应性)。另外根据性别和TNFi亚型

J Rheumatol:全身型幼年特发性关节炎疾病活动性的测量项目核心集

目前还没有关于全身型幼年特发性关节炎(sJIA)的标准化疾病活动性评估工具。这项研究旨在为sJIA开发一套疾病活动性测量集。

Stroke:活动性颅内动脉粥样硬化病的诊断和管理

颅内动脉粥样硬化性疾病(ICAD)是缺血性卒中的主要病因,常见于亚洲人、黑人和西班牙种群。MCA最常受累,其次是基底动脉、颈内动脉和椎动脉。ICAD的危险因素包括年龄、高血压、高脂血症和糖尿病。ICAD的卒中机制包括远端灌注受损,斑块破裂导致远端栓塞或分支闭塞。

Baidu
map
Baidu
map
Baidu
map